Analysts expect Sharps Compliance Corp. (NASDAQ:SMED) to announce earnings of $0.03 per share for the current fiscal quarter, according to Zacks. Three analysts have provided estimates for Sharps Compliance’s earnings, with estimates ranging from $0.01 to $0.04. Sharps Compliance reported earnings per share of $0.05 in the same quarter last year, which suggests a negative year-over-year growth rate of 40%. The firm is scheduled to report its next quarterly earnings results on Wednesday, January 22nd.
On average, analysts expect that Sharps Compliance will report full year earnings of $0.06 per share for the current fiscal year, with EPS estimates ranging from $0.04 to $0.07. For the next financial year, analysts expect that the firm will report earnings of $0.11 per share, with EPS estimates ranging from $0.10 to $0.13. Zacks’ earnings per share calculations are an average based on a survey of research analysts that that provide coverage for Sharps Compliance.
Sharps Compliance (NASDAQ:SMED) last issued its quarterly earnings data on Wednesday, October 23rd. The industrial products company reported $0.04 EPS for the quarter, topping analysts’ consensus estimates of $0.01 by $0.03. Sharps Compliance had a net margin of 1.74% and a return on equity of 3.16%. The business had revenue of $13.60 million during the quarter, compared to analysts’ expectations of $11.30 million.
Shares of NASDAQ:SMED traded up $0.04 on Friday, reaching $4.24. The company’s stock had a trading volume of 24,271 shares, compared to its average volume of 22,368. Sharps Compliance has a 52-week low of $2.97 and a 52-week high of $5.25. The company has a market cap of $67.82 million, a P/E ratio of 423.50, a PEG ratio of 3.21 and a beta of 0.25. The company has a 50-day simple moving average of $4.36 and a 200 day simple moving average of $3.88. The company has a debt-to-equity ratio of 0.30, a quick ratio of 1.66 and a current ratio of 1.99.
A number of hedge funds and other institutional investors have recently bought and sold shares of the business. Wells Fargo & Company MN increased its position in Sharps Compliance by 8.3% during the 2nd quarter. Wells Fargo & Company MN now owns 424,814 shares of the industrial products company’s stock valued at $1,512,000 after purchasing an additional 32,600 shares during the period. North Star Investment Management Corp. increased its position in Sharps Compliance by 9.8% during the 3rd quarter. North Star Investment Management Corp. now owns 271,575 shares of the industrial products company’s stock valued at $1,127,000 after purchasing an additional 24,150 shares during the period. Sunbelt Securities Inc. purchased a new position in Sharps Compliance during the 3rd quarter valued at about $872,000. Morgan Stanley increased its position in Sharps Compliance by 34.3% during the 2nd quarter. Morgan Stanley now owns 188,699 shares of the industrial products company’s stock valued at $672,000 after purchasing an additional 48,199 shares during the period. Finally, Lapides Asset Management LLC increased its position in Sharps Compliance by 13.3% during the 2nd quarter. Lapides Asset Management LLC now owns 164,700 shares of the industrial products company’s stock valued at $586,000 after purchasing an additional 19,300 shares during the period. 18.41% of the stock is currently owned by institutional investors and hedge funds.
About Sharps Compliance
Sharps Compliance Corp. provides medical, pharmaceutical, and hazardous waste management services in the United States. It offers Sharps Recovery System for the containment, transportation, treatment, and tracking of medical waste and used healthcare materials generated outside the hospital and health care facility settings; TakeAway Medication Recovery System, a solution that facilitates the proper disposal of unused medications; MedSafe, a solution for the safe collection, transportation, and proper disposal of unwanted and expired prescription medications; and ComplianceTRAC, a Web-based compliance and training program.
See Also: Bear Market
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Sharps Compliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sharps Compliance and related companies with MarketBeat.com's FREE daily email newsletter.